FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289654326> ?p ?o ?g. }

• W4289654326 abstract "Abstract Background Constitutive activation of PI3K signaling has been well recognized in a subset of small cell lung cancer (SCLC), the cancer type which has the most aggressive clinical course amongst pulmonary tumors. Whereas cancers that acquire a mutation/copy gain in PIK3CA or loss of PTEN have been implicated in enhanced sensitivity to inhibitors targeting the PI3K/AKT/mTOR pathway, the complexities of the pathway and corresponding feedback loops hamper clear predictions as to the response of tumors presenting these genomic features. Methods The correlation between the expression profile of proteins involved in the PI3K/AKT/mTOR signaling and cell viability in response to treatment with small molecule inhibitors targeting isoform-specific PI3Ks, AKT, and mTOR was assessed in 13 SCLC cancer cell lines. Athymic nude mice were used to determine the effect of PI3K/mTOR dual inhibition on the growth of xenograft SCLC tumors in vivo. The activation of caspase signaling and proteolytic cleavages of mTOR companion proteins were assessed using recombinant caspases assays and Western blot analyses. Results Our results indicate that the sensitivity of these SCLC cell lines to GSK2126458, a dual PI3K/mTOR inhibitor, is positively correlated with the expression levels of phosphorylated AKT (p-AKT) at Thr308 and Ser473. Inhibition of pan-class I PI3Ks or PI3K/mTOR dual inhibition was shown to induce proteolytic cleavage of RICTOR and RPTOR, which were respectively dependent on Caspase-6 and Caspase-3. A combination of a clinically approved PI3Kα-selective inhibitor and an mTORC1 inhibitor was shown to have synergistic effects in inducing the death of SCLC cells with high p-AKT. We observed no clear correlation between PTEN levels and the survival of SCLCs in response to PI3K/mTOR dual inhibition; however, PTEN depletion was shown to increase the susceptibility of low p-AKT SCLC cells to dual PI3K/mTOR inhibitor-induced cell death as well as the proteolytic cleavage of RICTOR. Conclusions These results suggest the level of p-AKT can be a companion diagnostic biomarker for the treatment of SCLC involving the combinational use of clinically approved isoform-specific PI3K and mTOR inhibitors." @default.
• W4289654326 created "2022-08-03" @default.
• W4289654326 creator A5006668892 @default.
• W4289654326 creator A5044218966 @default.
• W4289654326 creator A5046843986 @default.
• W4289654326 date "2022-08-02" @default.
• W4289654326 modified "2023-10-14" @default.
• W4289654326 title "AKT phosphorylation as a predictive biomarker for PI3K/mTOR dual inhibition-induced proteolytic cleavage of mTOR companion proteins in small cell lung cancer" @default.
• W4289654326 cites W1159008209 @default.
• W4289654326 cites W1601800607 @default.
• W4289654326 cites W1884032213 @default.
• W4289654326 cites W1903523058 @default.
• W4289654326 cites W1978286483 @default.
• W4289654326 cites W1981711832 @default.
• W4289654326 cites W1993760399 @default.
• W4289654326 cites W1995472430 @default.
• W4289654326 cites W1997232290 @default.
• W4289654326 cites W2000263590 @default.
• W4289654326 cites W2002226709 @default.
• W4289654326 cites W2015146110 @default.
• W4289654326 cites W2065620201 @default.
• W4289654326 cites W2082416335 @default.
• W4289654326 cites W2098060422 @default.
• W4289654326 cites W2106436765 @default.
• W4289654326 cites W2108927999 @default.
• W4289654326 cites W2113548725 @default.
• W4289654326 cites W2125149303 @default.
• W4289654326 cites W2128769524 @default.
• W4289654326 cites W2134138119 @default.
• W4289654326 cites W2153586332 @default.
• W4289654326 cites W2162821704 @default.
• W4289654326 cites W2169276102 @default.
• W4289654326 cites W2169303908 @default.
• W4289654326 cites W2178285892 @default.
• W4289654326 cites W2274924671 @default.
• W4289654326 cites W2340438210 @default.
• W4289654326 cites W2504750076 @default.
• W4289654326 cites W2514843686 @default.
• W4289654326 cites W2576845640 @default.
• W4289654326 cites W2593816418 @default.
• W4289654326 cites W2605336808 @default.
• W4289654326 cites W2802416980 @default.
• W4289654326 cites W2893960509 @default.
• W4289654326 cites W2910723008 @default.
• W4289654326 cites W2917964400 @default.
• W4289654326 cites W2923057410 @default.
• W4289654326 cites W2972827280 @default.
• W4289654326 cites W2974238339 @default.
• W4289654326 cites W2977392388 @default.
• W4289654326 cites W2996689167 @default.
• W4289654326 cites W3002154893 @default.
• W4289654326 cites W3003747453 @default.
• W4289654326 cites W3003807413 @default.
• W4289654326 cites W3014482292 @default.
• W4289654326 cites W3033738018 @default.
• W4289654326 cites W3109453522 @default.
• W4289654326 cites W3135092227 @default.
• W4289654326 cites W3158290259 @default.
• W4289654326 cites W4200503558 @default.
• W4289654326 cites W4237118278 @default.
• W4289654326 doi "https://doi.org/10.1186/s13578-022-00862-y" @default.
• W4289654326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35918763" @default.
• W4289654326 hasPublicationYear "2022" @default.
• W4289654326 type Work @default.
• W4289654326 citedByCount "1" @default.
• W4289654326 countsByYear W42896543262023 @default.
• W4289654326 crossrefType "journal-article" @default.
• W4289654326 hasAuthorship W4289654326A5006668892 @default.
• W4289654326 hasAuthorship W4289654326A5044218966 @default.
• W4289654326 hasAuthorship W4289654326A5046843986 @default.
• W4289654326 hasBestOaLocation W42896543261 @default.
• W4289654326 hasConcept C11960822 @default.
• W4289654326 hasConcept C185592680 @default.
• W4289654326 hasConcept C2777609662 @default.
• W4289654326 hasConcept C43060935 @default.
• W4289654326 hasConcept C502942594 @default.
• W4289654326 hasConcept C62478195 @default.
• W4289654326 hasConcept C75217442 @default.
• W4289654326 hasConcept C86554907 @default.
• W4289654326 hasConcept C86803240 @default.
• W4289654326 hasConcept C95444343 @default.
• W4289654326 hasConcept C98490376 @default.
• W4289654326 hasConceptScore W4289654326C11960822 @default.
• W4289654326 hasConceptScore W4289654326C185592680 @default.
• W4289654326 hasConceptScore W4289654326C2777609662 @default.
• W4289654326 hasConceptScore W4289654326C43060935 @default.
• W4289654326 hasConceptScore W4289654326C502942594 @default.
• W4289654326 hasConceptScore W4289654326C62478195 @default.
• W4289654326 hasConceptScore W4289654326C75217442 @default.
• W4289654326 hasConceptScore W4289654326C86554907 @default.
• W4289654326 hasConceptScore W4289654326C86803240 @default.
• W4289654326 hasConceptScore W4289654326C95444343 @default.
• W4289654326 hasConceptScore W4289654326C98490376 @default.
• W4289654326 hasFunder F4320322795 @default.
• W4289654326 hasIssue "1" @default.
• W4289654326 hasLocation W42896543261 @default.
• W4289654326 hasLocation W42896543262 @default.
• W4289654326 hasLocation W42896543263 @default.
• W4289654326 hasOpenAccess W4289654326 @default.
• W4289654326 hasPrimaryLocation W42896543261 @default.

• next